{
  "zip": "L6H 0M2",
  "sector": "Healthcare",
  "fullTimeEmployees": 6,
  "longBusinessSummary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BETEFLAM PATCH, a self-adhesive medicated plaster for the treatment of inflammatory skin conditions; BRINAVESS, a treatment for sinus rhythms in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-ISOTRETINOIN; LIPOFEN (CIP-FENOFIBRATE), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and CONZIP/DURELA (CIP-TRAMADOL ER), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products include TRULANCE, a once-daily tablet for the treatment of adults with chronic idiopathic constipation and irritable bowel syndrome with constipation; Trevyent, a drug device combination that delivers treprostinil, the treatment for pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for treatment of onychomycosis; and DTR-001 for tattoo removal. The company was founded in 2000 and is headquartered in Oakville, Canada.",
  "city": "Oakville",
  "phone": "905 602 5840",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.cipherpharma.com",
  "maxAge": 1,
  "address1": "209 Oak Park Boulevard",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "address2": "Suite 501",
  "previousClose": 0.85,
  "regularMarketOpen": 0.85,
  "twoHundredDayAverage": 0.8474101,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.85,
  "navPrice": null,
  "averageDailyVolume10Day": 14950,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.85,
  "fiftyDayAverage": 0.73151517,
  "trailingAnnualDividendRate": null,
  "open": 0.85,
  "averageVolume10days": 14950,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.197359,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.85,
  "priceHint": 4,
  "currency": "USD",
  "trailingPE": 3.0035338,
  "regularMarketVolume": 60,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 21904416,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 4753,
  "priceToSalesTrailing12Months": 1.0251997,
  "dayLow": 0.85,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 60,
  "fiftyTwoWeekHigh": 1.15,
  "forwardPE": 1.7,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.3,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.85,
  "exchange": "PNK",
  "shortName": "CIPHER PHARMACEUTICALS INC",
  "longName": "Cipher Pharmaceuticals Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CPHRF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_8201659",
  "uuid": "33ee6a68-9bd5-3305-98c7-75445d99f34d",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 1.016,
  "beta3Year": null,
  "profitMargins": 0.36319,
  "enterpriseToEbitda": 1.61,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": 0.5,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 27029000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 1.214,
  "sharesShort": 11427,
  "sharesPercentSharesOut": 0.0004,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 8.9999994e-05,
  "netIncomeToCommon": 7132000,
  "trailingEps": 0.283,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 0.7001648,
  "heldPercentInsiders": 0.40765,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": 0.97,
  "sharesShortPreviousMonthDate": 1477872000,
  "floatShares": 16104701,
  "enterpriseValue": 21704052,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1480464000,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": 48425,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.85,
  "logo_url": "https://logo.clearbit.com/cipherpharma.com"
}